BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38725860)

  • 1. TSPAN6 reinforces the malignant progression of glioblastoma via interacting with CDK5RAP3 and regulating STAT3 signaling pathway.
    Zhang C; Du FH; Wang RX; Han WB; Lv X; Zeng LH; Chen GQ
    Int J Biol Sci; 2024; 20(7):2440-2453. PubMed ID: 38725860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxic Cancer-Secreted Exosomal miR-182-5p Promotes Glioblastoma Angiogenesis by Targeting Kruppel-like Factor 2 and 4.
    Li J; Yuan H; Xu H; Zhao H; Xiong N
    Mol Cancer Res; 2020 Aug; 18(8):1218-1231. PubMed ID: 32366676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Annexin A2-STAT3-Oncostatin M receptor axis drives phenotypic and mesenchymal changes in glioblastoma.
    Matsumoto Y; Ichikawa T; Kurozumi K; Otani Y; Fujimura A; Fujii K; Tomita Y; Hattori Y; Uneda A; Tsuboi N; Kaneda K; Makino K; Date I
    Acta Neuropathol Commun; 2020 Apr; 8(1):42. PubMed ID: 32248843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomes of glioma cells deliver miR-148a to promote proliferation and metastasis of glioblastoma via targeting CADM1.
    Cai Q; Zhu A; Gong L
    Bull Cancer; 2018; 105(7-8):643-651. PubMed ID: 29921422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR‑378a‑3p inhibits cellular proliferation and migration in glioblastoma multiforme by targeting tetraspanin 17.
    Guo XB; Zhang XC; Chen P; Ma LM; Shen ZQ
    Oncol Rep; 2019 Nov; 42(5):1957-1971. PubMed ID: 31432186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRIM8 regulates stemness in glioblastoma through PIAS3-STAT3.
    Zhang C; Mukherjee S; Tucker-Burden C; Ross JL; Chau MJ; Kong J; Brat DJ
    Mol Oncol; 2017 Mar; 11(3):280-294. PubMed ID: 28100038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tetraspanin 6 (TSPAN6) negatively regulates retinoic acid-inducible gene I-like receptor-mediated immune signaling in a ubiquitination-dependent manner.
    Wang Y; Tong X; Omoregie ES; Liu W; Meng S; Ye X
    J Biol Chem; 2012 Oct; 287(41):34626-34. PubMed ID: 22908223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual PLK1 and STAT3 inhibition promotes glioblastoma cells apoptosis through MYC.
    Wang H; Tao Z; Feng M; Li X; Deng Z; Zhao G; Yin H; Pan T; Chen G; Feng Z; Li Y; Zhou Y
    Biochem Biophys Res Commun; 2020 Dec; 533(3):368-375. PubMed ID: 32962858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-type lectin domain family 5, member A (CLEC5A, MDL-1) promotes brain glioblastoma tumorigenesis by regulating PI3K/Akt signalling.
    Fan HW; Ni Q; Fan YN; Ma ZX; Li YB
    Cell Prolif; 2019 May; 52(3):e12584. PubMed ID: 30834619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smarcd1 Inhibits the Malignant Phenotypes of Human Glioblastoma Cells via Crosstalk with Notch1.
    Zhu Y; Wang H; Fei M; Tang T; Niu W; Zhang L
    Mol Neurobiol; 2021 Apr; 58(4):1438-1452. PubMed ID: 33190170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LRIG2 promotes the proliferation and cell cycle progression of glioblastoma cells in vitro and in vivo through enhancing PDGFRβ signaling.
    Xiao Q; Dong M; Cheng F; Mao F; Zong W; Wu K; Wang H; Xie R; Wang B; Lei T; Guo D
    Int J Oncol; 2018 Sep; 53(3):1069-1082. PubMed ID: 30015847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SH3GL3 acts as a novel tumor suppressor in glioblastoma tumorigenesis by inhibiting STAT3 signaling.
    Nie Z; Cai S; Wei Z; Li Y; Bian L; Wang C; Wang X; Wang C
    Biochem Biophys Res Commun; 2021 Mar; 544():73-80. PubMed ID: 33524871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CFTR activation suppresses glioblastoma cell proliferation, migration and invasion.
    Zhong X; Chen HQ; Yang XL; Wang Q; Chen W; Li C
    Biochem Biophys Res Commun; 2019 Jan; 508(4):1279-1285. PubMed ID: 30573361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of SH3GL2 promotes the migration and invasion behaviours of glioblastoma cells through activating the STAT3/MMP2 signalling.
    Zhu Y; Zhang X; Wang L; Ji Z; Xie M; Zhou X; Liu Z; Shi H; Yu R
    J Cell Mol Med; 2017 Nov; 21(11):2685-2694. PubMed ID: 28470949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Preclinical Investigation of GBM-N019 as a Potential Inhibitor of Glioblastoma via Exosomal mTOR/CDK6/STAT3 Signaling.
    Wu ATH; Huang HS; Wen YT; Lawal B; Mokgautsi N; Huynh TT; Hsiao M; Wei L
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular vesicles modulate the glioblastoma microenvironment via a tumor suppression signaling network directed by miR-1.
    Bronisz A; Wang Y; Nowicki MO; Peruzzi P; Ansari K; Ogawa D; Balaj L; De Rienzo G; Mineo M; Nakano I; Ostrowski MC; Hochberg F; Weissleder R; Lawler SE; Chiocca EA; Godlewski J
    Cancer Res; 2014 Feb; 74(3):738-750. PubMed ID: 24310399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Hippo-TAZ axis mediates vascular endothelial growth factor C in glioblastoma-derived exosomes to promote angiogenesis.
    Wang Z; Yuan Y; Ji X; Xiao X; Li Z; Yi X; Zhu Y; Guo T; Wang Y; Chen L; Liu Y
    Cancer Lett; 2021 Aug; 513():1-13. PubMed ID: 34010715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TSPAN6 is a suppressor of Ras-driven cancer.
    Humbert PO; Pryjda TZ; Pranjic B; Farrell A; Fujikura K; de Matos Simoes R; Karim R; Kozieradzki I; Cronin SJF; Neely GG; Meyer TF; Hagelkruys A; Richardson HE; Penninger JM
    Oncogene; 2022 Apr; 41(14):2095-2105. PubMed ID: 35184157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anlotinib combined with temozolomide suppresses glioblastoma growth via mediation of JAK2/STAT3 signaling pathway.
    Xu P; Wang H; Pan H; Chen J; Deng C
    Cancer Chemother Pharmacol; 2022 Feb; 89(2):183-196. PubMed ID: 34997858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the JAK-2/STAT3 signaling pathway impedes the migratory and invasive potential of human glioblastoma cells.
    Senft C; Priester M; Polacin M; Schröder K; Seifert V; Kögel D; Weissenberger J
    J Neurooncol; 2011 Feb; 101(3):393-403. PubMed ID: 20589525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.